Record Details

Patent Waiver on Covid Vaccine: Access for all or Global Supply Crisis?

NOPR - NISCAIR Online Periodicals Repository

View Archive Info
 
 
Field Value
 
Title Patent Waiver on Covid Vaccine: Access for all or Global Supply Crisis?
 
Creator Choudhary, Latika
Daga, Hardik
 
Subject Patent Waiver
Covid-19
Vaccine
World Trade Organization
Intellectual Property Rights
 
Description 420-426
The Coronavirus disease 2019 or COVID-19, pandemic has transpired disastrous effects in the world in multiple forms
ranging from the high death tolls to the steep fall in global economy. Even so, it had managed to provide a silver lining in
the form of unanimity of researchers from several disciplines, who united to contribute blood, sweat and tears to present to
the world the miracle of science- vaccines. One can only imagine the extent of investment which has gone into development
of the few vaccines we have today. In fact the research continues to be in full swing, with the hope and zest to better. While
every country fights the pandemic with vigor, it is the pharmaceutical R&D which is expected of breakthrough discoveries
as a solution. Where the pressure to succeed is tremendous, millions invested and no option to fail is it not justified to expect
and deserve patent for the same. This paper will dwell into the justification of patent over Covid-19 vaccines, the ongoing
debate over patent waiver and analyze whether the waiver will in fact facilitate greater access and affordability of vaccines
or prove to be an impediment for global supply.
 
Date 2023-01-25T06:40:20Z
2023-01-25T06:40:20Z
2023-01
 
Type Article
 
Identifier 0975-1076 (Online); 0971-7544 (Print)
http://nopr.niscpr.res.in/handle/123456789/61249
https://doi.org/10.56042/jipr.v27i6.62868
 
Language en
 
Publisher NIScPR-CSIR, India
 
Source JIPR Vol.27(6) [November 2022]